AAA
ASLN

Affinity Asset Advisors’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Affinity Asset Advisors’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,250
Closed -$445K – 77
2021
Q3 		$445K Buy
+6,250
New +$711K 0.11% 69
2021
Q2 		– Sell
-5,000
Closed -$670K – 82
2021
Q1 		$670K Buy
+5,000
New +$634K 0.23% 57

Other funds holding ASLN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Affinity Asset Advisors's ASLN Position: Q4 2021 in Review

Affinity Asset Advisors sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2021, closing a stake of 6,250 shares — an estimated $445K sold.

Affinity Asset Advisors first reported a position in ASLN in Q1 2021 and held it in 2 quarters. The position peaked at $670K in Q1 2021. 33 funds tracked by Wall St. Rank hold ASLN as of Q4 2021.

  • Affinity Asset Advisors reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Affinity Asset Advisors sold 6,250 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2021, an estimated $445K.
  • Affinity Asset Advisors first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Affinity Asset Advisors's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $670K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2021.

Based on Affinity Asset Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.